Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies
Arena Pharmaceuticals
William J Sandborn; Séverine Vermeire; Laurent Peyrin-Biroulet; Marla C Dubinsky; Julian Panes; Andres Yarur; Timothy Ritter; Filip Baert; Stefan Schreiber; Sheldon Sloan; Fabio Cataldi; Kevin Shan; Christopher J Rabbat; Michael Chiorean; Douglas C Wolf; Bruce E Sands; Geert D'Haens; Silvio Danese; Martina Goetsch; Brian G Feagan